Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2022 Sep 7;22:959. doi: 10.1186/s12885-022-10052-1

Retraction Note: K-ras-ERK1/2 down-regulates H2A.XY142ph through WSTF to promote the progress of gastric cancer

Chao Dong 1, Jing Sun 2, Sha Ma 2, Guoying Zhang 2,
PMCID: PMC9450263  PMID: 36071398

Retraction Note: BMC Cancer 19, 530 (2019)

https://doi.org/10.1186/s12885-019-5750-x

The Editor has retracted this article. Concerns have been raised about a number of figures in this article:

  • In Figure 1A and 1C it appears that the Western blot quantification doesn't match the images presented. In addition, the label for the y axis does not match the Western blot label it is supposed to quantify in 1A.

  • In Figure 6 it appears that the image used for Anti-GFP in Figure 6B and 6C are the same.

The authors stated that the figures were obtained through a commercial lab hired to perform some of the experiments for this study. The authors didn't receive the raw data and couldn't share it with the journal. They were also unable to reproduce the findings in their own follow up experiments. The Editor therefore no longer has confidence in the integrity of the data in this article.

Author Guoying Zhang has stated on behalf of all co-authors that they agree to this retraction.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES